Promoter hypermethylation as a biomarker in prostate adenocarcinoma
JY Park - … risk Assessment, Diagnosis, Treatment, and Prognosis, 2015 - Springer
There is increasing evidence that DNA methylation is a critical source of gene regulation. In
addition, interindividual differences in DNA methylation status in cancer related genes are …
addition, interindividual differences in DNA methylation status in cancer related genes are …
DNA methylation in promoter region as biomarkers in prostate cancer
M Yang, JY Park - Cancer Epigenetics: Methods and Protocols, 2012 - Springer
The prostate gland is the most common site of cancer and the second leading cause of
cancer death in American men. Recent emerging molecular biological technologies help us …
cancer death in American men. Recent emerging molecular biological technologies help us …
Promoter hypermethylation in prostate cancer
JY Park - Cancer Control, 2010 - journals.sagepub.com
Background The prostate gland is the most common site of cancer and the second leading
cause of cancer mortality in American men. It is well known that epigenetic alterations such …
cause of cancer mortality in American men. It is well known that epigenetic alterations such …
DNA methylation in prostate cancer
Prostate cancer is the most common malignancy and the second leading cause of cancer
death among men in the United States. There are three well-established risk factors for …
death among men in the United States. There are three well-established risk factors for …
DNA methylation changes in prostate cancer: current developments and future clinical implementation
MO Hoque - Expert review of molecular diagnostics, 2009 - Taylor & Francis
Promoter hypermethylation is associated with the loss of expression of tumor-suppressor
genes in cancer. Currently, several genome-wide technologies are available and have been …
genes in cancer. Currently, several genome-wide technologies are available and have been …
Aberrant DNA methylation and prostate cancer
S Majumdar, E Buckles, J Estrada… - Current …, 2011 - ingentaconnect.com
Prostate cancer (PCa) is the most prevalent cancer, a significant contributor to morbidity and
a leading cause of cancer-related death in men in Western industrialized countries. In …
a leading cause of cancer-related death in men in Western industrialized countries. In …
Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia
JM Devaney, S Wang, S Funda, J Long… - Prostate cancer and …, 2013 - nature.com
Background: Prostate cancer (PCa) harbors a myriad of genomic and epigenetic defects.
Cytosine methylation of CpG-rich promoter DNA is an important mechanism of epigenetic …
Cytosine methylation of CpG-rich promoter DNA is an important mechanism of epigenetic …
[HTML][HTML] DNA hypermethylation associated with upregulated gene expression in prostate cancer demonstrates the diversity of epigenetic regulation
I Rauluseviciute, F Drabløs, MB Rye - BMC medical genomics, 2020 - Springer
Abstract Background Prostate cancer (PCa) has the highest incidence rates of cancers in
men in western countries. Unlike several other types of cancer, PCa has few genetic drivers …
men in western countries. Unlike several other types of cancer, PCa has few genetic drivers …
A DNA hypermethylation profile reveals new potential biomarkers for prostate cancer diagnosis and prognosis
N Ashour, JC Angulo, G Andrés, R Alelú… - The …, 2014 - Wiley Online Library
BACKGROUND DNA hypermethylation has emerged as a novel molecular biomarker for the
evaluation of prostate cancer diagnosis and prognosis. Defining the specific gene …
evaluation of prostate cancer diagnosis and prognosis. Defining the specific gene …
Diagnosis and prognosis potential of four gene promoter hypermethylation in prostate cancer
Y Li, L Meng, T Shi, J Ren, Q Deng - Cell Biology International, 2021 - Wiley Online Library
The current prostate special antigen (PSA) test causes the overtreatment of indolent prostate
cancer (PCa). It also increases the risk of delayed treatment of aggressive PCa. DNA …
cancer (PCa). It also increases the risk of delayed treatment of aggressive PCa. DNA …
相关搜索
- promoter hypermethylation prostate adenocarcinoma
- dna methylation prostate cancer
- promoter region dna methylation
- epigenetic regulation dna hypermethylation
- gene expression dna hypermethylation
- promoter hypermethylation prostate cancer
- dna hypermethylation prostate cancer
- promoter region prostate cancer
- epigenetic regulation prostate cancer
- gene expression prostate cancer